All News

Interior design laboratory

Transfer, New Research Findings, Diabetes, IDO,

New Drug Candidate Developed to Treat Type 2 Diabetes

A team of researchers from Helmholtz Munich, the German Center for Diabetes Research (DZD) and Novo Nordisk have developed a new hormone combination for the future treatment of type 2 diabetes. The scientists have combined the blood sugar-reducing…

IDO, Institute for Diabetes and Obesity

Awards & Grants, Diabetes, IDO, Pioneer Campus,

Two-Pack of Success – Timo Müller and Ben Engel Receive ERC Consolidator Grant

Helmholtz Munich obtains two ERC Consolidator Grants: Timo Müller from the Institute for Diabetes and Obesity with "TRUSTED", and Ben Engel, formerly of the Helmholtz Pioneer Campus, with "cryOcean". They are among the successful 12 percent to…

Paul Pfluger and André Stiel

Awards & Grants, IDO, IBMI,

ERC Grant Success Continues for Helmholtz Zentrum München

Helmholtz Zentrum München won two ERC Consolidator Grants for pioneering biomedical research in the fields of metabolic health and bioengineering. In 2020, the European Research Council (ERC) awarded the center with a total of eight ERC Grants. This…